leukeran tablet
aspen pharmacare canada inc. - chlorambucil - tablet - 2mg - chlorambucil 2mg - antineoplastic agents
leukeran
excella gmbh & co.kg - chlorambucil - tablets film-coated - 2mg
leukeran tablets film-coated
excella gmbh & co.kg - chlorambucil - tablets film-coated - 2mg
leukeran 2 mg film-coat. tabl.
aspen pharma trading ltd. - chlorambucil 2 mg - film-coated tablet - 2 mg - chlorambucil 2 mg - chlorambucil
leukeran 2mg tablets
lexon (uk) ltd - chlorambucil - oral tablet - 2mg
leukeran tablets 2mg
aspen medical products malaysia sdn bhd - chlorambucil -
leukeran
aspen pharmacare australia pty ltd - chlorambucil -
leukeran tablets 2 mg
مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - chlorambucil 2 mg - 2 mg
arzerra
novartis europharm ltd - ofatumumab - leukemia, lymphocytic, chronic, b-cell - monoclonal antibodies - previously untreated chronic lymphocytic leukaemia (cll): arzerra in combination with chlorambucil or bendamustine is indicated for the treatment of patients with cll who have not received prior therapy and who are not eligible for fludarabine-based therapy. relapsed cll: arzerra is indicated in combination with fludarabine and cyclophosphamide for the treatment of adult patients with relapsed cll. refractory cll: arzerra is indicated for the treatment of cll in patients who are refractory to fludarabine and alemtuzumab.,
leukeran 2 mg
pharmacare limited - chlorambucil - tablets - each tablet contains chlorambucil 2,0 mg